While Elevance Health Inc has overperformed by 2.56%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ELV fell by -13.18%, with highs and lows ranging from $567.26 to $362.21, whereas the simple moving average fell by -15.14% in the last 200 days.
On January 22, 2025, Stephens Downgraded Elevance Health Inc (NYSE: ELV) to Equal-Weight. A report published by Argus on October 18, 2024, Downgraded its rating to ‘Hold’ for ELV. BofA Securities also Downgraded ELV shares as ‘Neutral’, setting a target price of $530 on the company’s shares in a report dated July 18, 2024. Morgan Stanley Initiated an Overweight rating on June 24, 2024, and assigned a price target of $643. Robert W. Baird initiated its ‘Outperform’ rating for ELV, as published in its report on May 30, 2024. Barclays’s report from March 06, 2024 suggests a price prediction of $584 for ELV shares, giving the stock a ‘Overweight’ rating. Wolfe Research also rated the stock as ‘Peer Perform’.
Analysis of Elevance Health Inc (ELV)
With ELV’s current dividend of $6.52 per share, investors can expect to earn a return regardless of performance. Further, the quarter-over-quarter increase in sales is 6.55%, showing a positive trend in the upcoming months.
Elevance Health Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 14.83% is sufficient for you to turn a profit off your investment.
The average volume for any stock is also a very valuable indicator of volatility, and ELV has an average volume of 1.91M. On a monthly basis, the volatility of the stock is set at 2.39%, whereas on a weekly basis, it is put at 2.94%, with a gain of 6.74% over the past seven days. Furthermore, long-term investors anticipate a median target price of $484.72, showing growth from the present price of $411.24, which can serve as yet another indication of whether ELV is worth investing in or should be passed over.
How Do You Analyze Elevance Health Inc Shares?
Healthcare Plans giant Elevance Health Inc (ELV) is based in the USA and is one of the largest companies in the market. When comparing Elevance Health Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 16.06, there is a growth in quarterly earnings of -50.18%.
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.21%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 90.38% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ELV shares are owned by institutional investors to the tune of 90.38% at present.
